Sophos Anti-Virus reaffirms 100% detection award from Virus Bulletin

Sophos Press Release

WOBURN, MA -- Sophos, the leading developer of network anti-virus software, today announced it has been awarded the VB 100% detection certification from the February issue of Virus Bulletin, the international publication on computer virus prevention.

Following on from the January testing of Windows 95 products, eighteen DOS products were submitted for testing this month. Virus Bulletin focused on the detection rate and speed for this review. Other notable products submitted, which failed to achieve the VB 100% certificate, included Symantec's Norton Anti-Virus and Trend Micro's PC-cillen.

The award means that Sophos Anti-Virus detected all samples from Virus Bulletin's In The Wild File and In the Wild Boot virus collections. "Obviously we're very pleased to receive this prestigious award for the 2nd month running." said Richard Jacobs, President of Sophos, Inc. "This provides independent confirmation of the quality and timeliness of our virus detection. It is this consistency both from month to month and across multiple platforms that our customers value. Few manufacturers can match this."

"Sophos has earned itself another VB 100% award in this review, turning in near perfect detection across the test-sets." Commented Virus Bulletin, "Not surprisingly, SWEEP (Sophos Anti-Virus) did not report any false positives in the Clean test-set...SWEEP (Sophos Anti-Virus) is faster than several of its competitors which boast similarly impressive detection rates."

More than 100 million users in 150 countries rely on Sophos’ complete security solutions as the best protection against complex threats and data loss. Simple to deploy, manage, and use, Sophos’ award-winning encryption, endpoint security, web, email, mobile and network security solutions are backed by SophosLabs - a global network of threat intelligence centers. Sophos is headquartered in Oxford, U.K., and is publicly traded on the London Stock Exchange under the symbol “SOPH.” More information is available at